Classifications

• • C—CHEMISTRY; METALLURGY
  • C07—ORGANIC CHEMISTRY
  • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
  • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
  • C07F9/02—Phosphorus compounds
  • C07F9/28—Phosphorus compounds with one or more P—C bonds
  • C07F9/50—Organo-phosphines
  • C07F9/505—Preparation; Separation; Purification; Stabilisation
  • C07F9/5063—Preparation; Separation; Purification; Stabilisation from compounds having the structure P-H or P-Heteroatom, in which one or more of such bonds are converted into P-C bonds
  • C07F9/5068—Preparation; Separation; Purification; Stabilisation from compounds having the structure P-H or P-Heteroatom, in which one or more of such bonds are converted into P-C bonds from starting materials having the structure >P-Hal
• • C—CHEMISTRY; METALLURGY
  • C07—ORGANIC CHEMISTRY
  • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
  • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
  • C07F9/02—Phosphorus compounds
  • C07F9/28—Phosphorus compounds with one or more P—C bonds
  • C07F9/50—Organo-phosphines
  • C07F9/5036—Phosphines containing the structure -C(=X)-P or NC-P
• • C—CHEMISTRY; METALLURGY
  • C07—ORGANIC CHEMISTRY
  • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
  • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
  • C07F9/02—Phosphorus compounds
  • C07F9/28—Phosphorus compounds with one or more P—C bonds
  • C07F9/50—Organo-phosphines
  • C07F9/53—Organo-phosphine oxides; Organo-phosphine thioxides
  • C07F9/5337—Phosphine oxides or thioxides containing the structure -C(=X)-P(=X) or NC-P(=X) (X = O, S, Se)

Definitions

• the present invention relates to a new, selective process for the preparation of bisacyl- phosphanes, bisacylphosphane oxides or bisacylphosphane sulfides.
• Methods of industrial Bapo synthesis are based on acylation of in situ prepared phenyl- phosphanes or its alkali salt as a key step. Due to its dangerous properties such as high toxicity and pyrophoric character, phenylphosphane is not available as a raw material on the market anymore.
• the European Patent Publication WO00/32612 corresponding to EP1 135 399 B1 describes a process for the preparation of bisacylphosphanes, bisacylphosphane oxides and of bisacylphosphane sulfides, which process comprises first reacting organic P-monohalogeno- phosphanes or P, P-dihalogenophosphanes or mixtures thereof, with an alkali metal or magnesium in combination with lithium, where appropriate in the presence of a catalyst, and then carrying out the reaction with acid halides and, in the case of the process for the preparation of oxides, carrying out an oxidation step and, in the case of the preparation of sulfides, reacting the phosphanes so obtained with sulfur.
• WO00/32612 uses the same starting materials as the presently claimed process but does not proceed via the hydride instead of a metal salt before reaction with the acid chloride.
• the British Publication GB2310855 describes the preparation of methylphenylphosphine by lithium aluminium hydride reduction of 4-methylphenyldiethylphosphonate.
• the International Publication WO05/014605 describes a process to prepare bisacyl- phosphanes, which process comprises first reacting organic P-monohalogenophosphanes (R 2 PCI) or P, P-dihalogenophosphanes (RPCI 2 ), or phosphorus halide oxide or phosphorus halide sulfide with an alkali metal (metallation) in a solvent in the presence of a proton source (reduction), and where appropriate in the presence of a catalyst, and then carrying out the reaction with acid halides.
• R 2 PCI organic P-monohalogenophosphanes
• RPCI 2 P, P-dihalogenophosphanes
• the International Publication WO04/050668 describes a process to prepare cycloorganyl phosphanes of the formula (R 1 P) n by reacting R 1 PHaI 2 with an alkali metal or an alkaline- earth metal in an organic solvent such as toluene in the presence of an activator.
• the Japanese Publication JP 2000 007689 is addressed to the problem of phosphane preparation.
• Mono-chlorodiphenylphosphanes are hydrogenated in the presence of N,N-di- methylformamide and an amine.
• the process has the drawback that phenylphosphane cannot be obtained starting from dichlorophenylphosphanes as shown in the comparative example.
• the invention relates to a process for the preparation of bis-acyl phosphanes of formula I
• R 1 is unsubstituted phenyl or phenyl substituted by one to five halogen, Ci-C 8 -alkyl, CrC 8- alkylthio and/or C r C 8 -alkoxy;
• R 10 is hydrogen, C r Ci 8 -alkyl, or C 2 -Ci 8 -alkyl which is interrupted by one or several non- successive -O-atoms, C 5 -Ci 2 -cycloalkyl, phenyl-CrC 4 -alkyl, C 2 -Ci 8 -alkenyl, phenyl, naphthyl or biphenyl being unsubstituted or substituted by one to five Ci-C 8 -alkyl, C r Cs-alkoxy, CrC 8 -alkylthio and/or halogen;
• R 11 is hydrogen, CrCi 8 -alkyl, C 2 -Ci 8 -alkyl which is interrupted by one or several non- successive O atoms, C 5 -Ci 2 -cycloalkyl, C 2 -Ci 8 -alkenyl, phenyl-CrC 4 -alkyl, phenyl, naphthyl, pyridyl, the radicals phenyl, naphthyl or pyridyl being unsubstituted or substituted by one to five Ci-C 8 -alkyl, Ci-C 8 -alkoxy, d-C 8 -alkylthio and/or halogen; the process comprises the steps in a) selective reduction of dichlorophenylphosphanes of the formula Il
• R 2 COHaI wherein R 2 is as defined above.
• the phenylphosphanes are obtained in high yield and with high selectivity. Furthermore it is possible to stop the reaction at an intermediate stage with selective formation of cyclic phenylphosphanes, potentially valuable compound for further transformations.
• Ci 8 -alkyl is linear or branched and is, for example, CrCi 2 -, CrC 8 -, CrC 6 - or CrC 4 alkyl. Examples are methyl, ethyl, propyl, isopropyl, n-butyl, sec-butyl, isobutyl, tert-butyl, pentyl, hexyl, heptyl, 2,4,4-trimethylpentyl, 2-ethylhexyl, octyl, nonyl, decyl, undecyl, dodecyl, tetra- decyl, pentadecyl, hexadecyl, heptadecyl or octadecyl.
• C 2 -Ci 8 -alkenyl radicals may be mono- or polyunsaturated, linear or branched and are, for example, vinyl, allyl, methallyl, 1 ,1 -dimethylallyl, propenyl, butenyl, pentadienyl, hexenyl or octenyl, preferably vinyl or allyl.
• Cycloalkyl is, for example, cyclopentyl, cyclohexyl, cyclooctyl, cyclododecyl, preferably cyclopentyl and cyclohexyl, more preferably cyclohexyl.
• d-Cs-alkoxy is linear or branched radicals and is typically methoxy, ethoxy, propoxy, isopro- poxy, n-butyloxy, sec-butyloxy, isobutyloxy, tert-butyloxy, pentyloxy, hexyloxy, heptyloxy, 2,4,4-trimethylpentyloxy, 2-ethyl hexyloxy or octyloxy, preferably methoxy, ethoxy, propoxy, isopropoxy, n-butyloxy, sec-butyloxy, isobutyloxy, tert-butyloxy, most preferably methoxy.
• Examples of -O-, S- or N-containing 5- or 6-membered heterocyclic rings are furyl, thienyl, pyrrolyl, oxinyl, dioxinyl or pyridyl.
• the cited heterocyclic radicals may be substituted by one to five, e.g. by one or two, linear or branched CrC 8 -alkyl, halogen and/or CrC 8 -alkoxy. Examples of such compounds are dimethylpyridyl, dimethyl pyrrolyl or methylfuryl.
• Substituted phenyl, naphthyl or biphenyl is substituted by one to five, e.g. by one, two, three or four, preferably by one, two or three, for example linear or branched CrC 8 -alkyl, linear or branched Ci-C 8 -alkoxy or by halogen.
• Preferred substituents for phenyl, naphthyl and biphenyl are Ci-C 4 -alkyl, e.g. methyl, C r C 4 - alkoxy, e.g. methoxy, and chloro.
• substituents are, for example, 2,4,6- trimethylphenyl, 2,6-dichlorophenyl, 2,6-dimethylphenyl or 2,6-dimethoxyphenyl.
• R 2 is, for example, Ci-Ci 8 -alkyl or phenyl, preferably 2,4,6-trimethylphenyl, 2, 6-di methyl - phenyl or 2,6-dimethoxyphenyl, ferf-butyl, 1,1-diphenylethyl, 2-phenylpropyl, 2-methyl butyl, 2-methylpentyl, most preferably 2,4,6-trimethylphenyl.
• R 1 is unsubstituted phenyl.
• the hydrogenation catalyst is a reduction catalyst.
• Preferred catalysts include, but are not limited to, ruthenium (Ru), rhenium (Re), rhodium (Rh), platinum (Pt), palladium (Pd), copper (Cu), nickel (Ni), cobalt (Co), molybdenum (Mo), copper chromite, including various oxides and Raney forms thereof.
• Supports may include carbon (C), niobium (Nb), titania (TiO 2 ), zirconia (ZrO 2 ), silica (SiO 2 ), tin (Sn), alumina (AI 2 O 3 ) or mixtures thereof.
• Especially preferred catalysts include palladium on carbon and palladium on alumina. Suitable amounts are 0.5wt% to 30wt%Pd, preferably 5wt% to 10wt%.
• tertiary amine among others includes alkylamines such as: triethylamine, tributylamine, benzyldialkylamine, N-alkylmorpholine, N-alkylpiperidine, N-alkylpyrrolidine, or aromatic amines such as pyridine, 2 or 3 or 4-methylpyridine, 2,3 or 2,4 or 2,5 or 2,6 or 3,4 or 3,5-dimethylpyridine, N,N-dialkylaniline, e.g. N,N-dimethylaniiine, or mixtures thereof.
• Preferred is pyridine or triethylamine, especially preferred is pyridine.
• non-protic solvent which is unreactive under hydrogenation reactions refers to aromatic hydrocarbons such as benzene, toluene, xylenes, and the like; Ethers such as DME (1 ,2-dimethoxyethane), isopropylether, dioxanes, diglyme, triglyme, anisol and the like; aliphatic hydrocarbons such as hexanes, heptanes, octanes, and the like; esters such as tert.butylester, isopropylester, and the like; N-Ci-C 6 -alkylimidazoles, N-Ci-C 6 -alkyl-1 ,2,4- triazoles and mixtures thereof. Preferred are toluene or xylene.
• the success of the reaction according to the invention is mainly dependent on the use of the appropriate solvent, base, catalyst and reaction temperature chosen.
• the hydrogenation process is preferably carried out at 80 to 25O 0 C preferably at 100-180 0 C, in particular at 115-16O 0 C, and 25 to 250 bar, preferably at 50 to 250 bar hydrogen pressure.
• the hydrogenation process is preferably carried out at 20 to 200°C preferably at 50-18O 0 C, in particular at 80-100°C, and 1 to 20 bar, preferably at 1 to 10. bar hydrogen pressure.
• the catalyst can be separated off after the reaction by the usual methods.
• cyclic phenylphosphanes obtained in step a) or the phenylphosphanes obtained in step b) can be further reacted with acid halides R 2 COHaI (III) to bisacylphosphanes of the formula I.
• the solvents used in step c) may be, for example, the same as those used above for the first step. However, it is also possible to remove the solvent used in the first step by distillation and to take up the residue in another solvent and then to further process it. It is preferred to work in the same solvent as in the preceding step, preferably in xylene or toluene.
• a base has to be added.
• a suitable base is NaOH, KOH, LiOH, alcoholates such as tert. butylalcoholate, tetraalkylphosphonium salts, tetraarylphosphonium salts, tetraalkylammonium salts, tetraarylammonium salts and the like.
• reaction temperatures for the reaction with the acid halide are usefully in the range from -20° to +8O 0 C.
• the bisacylphosphane of formula I can be isolated by the customary technological methods which are known to the skilled person, for example by filtration, evaporation or distillation. Likewise, the customary methods of purification may be used, for example crystallisation, distillation or chromatography.
• the phosphanes can also be reacted without isolation to the corresponding bisacylphosphane oxides or bisacylphosphane sulfides.
• This process is first carried out as described above and a bisacylphosphane (I) is prepared.
• the crude reaction product (I) can then be further processed without purification.
• the oxidation of the phosphane (I) is carried out using the oxidant conventionally used in the technology.
• Suitable oxidants are in particular hydrogen peroxide and organic peroxy compounds, for example peracetic acid or t- butylhydroperoxide, air or pure oxygen.
• Suitable solvents are aromatic hydrocarbons, such as benzene, toluene, m-xylene, p-xylene, ethylbenzene or mesitylene, or aliphatic hydrocarbons, such as alkanes and alkane mixtures, e.g. petroleum ether, hexane or cyclo- hexane.
• the reaction temperature is preferably kept in the range from 0° to 12O 0 C, preferably from 20° and 8O 0 C.
• reaction products can be isolated and purified by conventional processing methods known to the skilled person.
• the respective sulfide is prepared by reaction with sulfur:
• the bisacylphosphanes (I) are in this case reacted in substance or, where appropriate, in a suitable inert organic solvent with an equimolar to 2-fold molar amount of elementary sulfur.
• Suitable solvents are for example those described for the oxidation reaction. However, it is also possible to use e.g. aliphatic or aromatic ethers, such as dibutyl ether, dioxane, diethylene glycol dimethyl ether or diphenyl ether, in the temperature range from 20° to
• the resulting bisacylphosphane sulfide, or its solution, is usefully freed from any remaining elementary sulfur by filtration. After the solvent is removed, the bisacylphosphane sulfide can be isolated by distillation, chromatography or re- crystallisation in pure form.
• the acid halides (III), used as starting materials are known substances, some of which are commercially available, or may be prepared in analogy to known compounds.
• phosphane oxides and phosphane sulfides are used in the art as initiators in photopolymerisation reactions.
• Examplei Preparation of pentaphenyl-pentaphospholane (PhP) 5
• PhP pentaphenyl-pentaphospholane
• a 100 mL glass autoclave equipped with an agitator is charged with toluene (20 ml_), pyridine (20 mL), palladium on activated carbon (10% Pd, 0.15 g) and dichlorophenylphosphane (1.80 g, 0.01 mol) under argon atmosphere.
• the hydrogen pressure is set to 5 bar and the temperature is raised to 80 0 C while stirring.
• a 100 mL stainless steel autoclave equipped with an agitator is charged with toluene (25 mL), pyridine (25 mL), palladium on activated carbon (10% Pd, 0.50 g) and dichlorophenyl- phosphane (4.50 g, 0.025 mol). under argon atmosphere.
• the hydrogen pressure is set to 20 bar and the temperature is raised to 150°C while stirring. When the temperature has reached 150 0 C, the hydrogen pressure is set to 50 bar.
• the autoclave is cooled to room temperature and a sample is taken for 31 P-NMR, showing that all dichlorophenylphosphane has been converted.
• a 100 ml. glass autoclave equipped with an agitator is charged with 20 ml. of DMF, 20 ml. of triethylamine, 0.15 g of 10% palladium on activated carbon and 1.80 g (0.01 mol) dichlorophenylphosphane under argon atmosphere.
• the hydrogen pressure is set to 5 bar and kept at 5 bar while stirring.
• a sample is taken and analyzed by 31 P-NMR 1 spectroscopy showing that some dichlorophenylphosphane has been converted (s, 163 ppm).
• the main products showed 31 P-NMR signals at 77 ppm (s), 3 to -3 ppm (m), respectively. According to 31 P-NMR, the reaction mass does not contain any phenylphosphane.
• the hydrogen pressure is then set again to 5 bar and the temperature is increased to 50 0 C.
• the autoclave is cooled to room temperature and an again an analytical sample for 31 P-NMR is taken.
• the 31 P-NMR shows that all dichlorophenylphosphane has been converted and that various phosphorus containing products (s, 24 ppm; m, 11 to -5 ppm; s, 48 ppm) have been formed but still no phenylphosphane can be detected.

Landscapes

• Chemical & Material Sciences (AREA)
• Organic Chemistry (AREA)
• Health & Medical Sciences (AREA)
• Life Sciences & Earth Sciences (AREA)
• Biochemistry (AREA)
• General Health & Medical Sciences (AREA)
• Molecular Biology (AREA)
• Crystallography & Structural Chemistry (AREA)
• Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
• Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Priority Applications (4)

Applications Claiming Priority (2)

Publications (1)

Family

ID=34979152

Family Applications (1)

Country Status (6)

Cited By (8)

Families Citing this family (1)

Citations (5)

Family Cites Families (4)

• 2006
  • 2006-01-09 US US11/795,059 patent/US7470819B2/en active Active
  • 2006-01-09 JP JP2007550781A patent/JP5234912B2/ja active Active
  • 2006-01-09 AT AT06701700T patent/ATE538126T1/de active
  • 2006-01-09 WO PCT/EP2006/050081 patent/WO2006074983A1/en not_active Ceased
  • 2006-01-09 EP EP06701700A patent/EP1838721B1/en active Active
  • 2006-01-16 TW TW095101582A patent/TWI370133B/zh active

Patent Citations (5)

Non-Patent Citations (5)

Also Published As

Similar Documents

Legal Events